http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19804673-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ddfc936c889d46963b2fdafe0d45506
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D245-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D321-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D315-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B37-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D327-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D323-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B37-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D321-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D245-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D315-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D313-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-08
filingDate 1998-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74a8301d12f4a29865e57e2dcda1c617
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_daa7a89b3e17fea4ead091176e364407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66bc0dfb196877b49fcd639ab52eb43c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc2a65efdb70c97bfa035b9acc413b36
publicationDate 1999-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-19804673-A1
titleOfInvention Process for the preparation of macrocyclic products by ring-closing diine metathesis
abstract The invention relates to methods for preparing macrocyclic products with 9 or more ring atoms by ring-closing diine metathesis of suitable diine substrates. The diine substrates can be converted into cycloakynes or into cycloalkadiines by cyclodimerisation, depending on the particular reaction conditions. Any alkyne metathesis catalyst can be used as the catalyst, regardless of whether they are heterogeneously or homogeneously present in the reaction medium. The preferred catalysts or pre-catalysts are transition metal alkylidine complexes, transition metal compounds which form alkylidine complexes under the reaction conditions, and transition metal compounds with metalmetal triple bonds. The method can be carried out with numerous functional groups, solvents and additives. The macrocyclic cycloalkynes or cycloalkadiines formed can be converted into numerous secondary products using known methods, especially macrocyclic cycloalkenes with a uniform configuration of the double bond, and used e.g. for synthesising epothilone or epothilone analogues.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8217185-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8946364-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009039675-A1
priorityDate 1998-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5391726-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451989532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412117526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7551
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419575326
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7406
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546748
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414022007
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123318
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414869987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411062137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521738
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51052073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578768
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419511972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415968435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20565003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13568
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422808907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6326969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970

Total number of triples: 78.